Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Maternal Cardiac Function in Pregnancies With Metabolic Disorders
Author(s): Deesha Patel , Makrina D Savvidou Added: 11 months ago

Imaging & Diagnostics

Prevention & Chronic Conditions
Pre-eclampsia and CVD
Author(s): Veronica Giorgione , Matthew Cauldwell , Basky Thilaganathan Added: 1 year ago

Demographic

Prevention & Chronic Conditions
ACC 25: Cardiac Biomarker Analysis from the EARLY TAVR Trial
Author(s): Brian Lindman Added: 1 month ago
ACC 2025 - Primary findings from EARLY-TAVR show the benefit of early TAVR intervention was consistent across biomarker subgroups.Dr Brian Lindman (Vanderbilt University Medical Center, Nashville, US) joins us onsite at ACC 2025 to discuss findings from the primary biomarker analysis from the EARLY TAVR trial (NCT03042104; Edwards Lifesciences). The analysis investigated cardiac biomarkers in… View more

Vascular Disease and Surgery
ESC HF 25: CRISPR in ATTR-CM: Hereditary vs Wild-Type
Author(s): Marianna Fontana Added: 3 days ago
ESC HF 25 - A study investigating CRISPR gene editing with nexiguran ziclumeran in ATTR cardiomyopathy demonstrated favourable safety and tolerability, with consistent reductions in serum TTR in both wild-type and variant disease.Prof Marianna Fontana (University College London, UK) joins us to discuss the key findings from a two-part, open-label, phase 1 study investigating the treatment effect,… View more

Heart Failure
ESC HF 25: The Heart2Miss Study
Author(s): Diana Hui Ping Foo Added: 1 day ago
ESC HF 25 - Findings from Heart2Miss suggest a hub-and-spoke model for early heart failure detection can detect patients with pre-HF and HF who were previously undiagnosed, can reduce tertiary center overload and improve novice performance.Dr Diana Foo (Sarawak General Hospital, Kuching, MY) discusses the findings from the Heart2Miss study, investigating a decentralised, community-based, rapid,… View more

Heart Failure

Imaging & Diagnostics
Kawasaki Disease: A Never-ending Story?
Author(s): Alessandro Cavalcanti Lianza , Maria de Fátima Rodrigues Diniz , Karen Saori Shiraishi Sawamura , et al Added: 1 year ago

Vascular Disease and Surgery

Imaging & Diagnostics
2024 ESC Guidelines on Peripheral Arterial and Aortic Diseases
Author(s): Giuseppe Ferrante , Brittany A Bacallao , Francesco Gioia , et al Added: 5 months ago

Vascular Disease and Surgery
Cardiac Involvement Due to COVID-19
Author(s): Valentina O Puntmann , Anastasia Shchendrygina , Carlos Rodriguez Bolanos , et al Added: 1 year ago

Imaging & Diagnostics

COVID-19
EMPA-KIDNEY: Empagliflozin in Patients with Chronic Kidney Disease
Author(s): William Herrington Added: 6 months ago
Long-term cardio-renal outcomes investigating empagliflozin (Boehringer Ingelheim) on kidney disease progression (KDP) or cardiovascular death in patients with pre-existing chronic kidney disease.In this short interview, Prof William Herrington (Nuffield Department of Population Health, University of Oxford, Oxford, UK) discusses the findings from EMPA-KIDNEY (NCT03594110).EMPA-KIDNEY is an… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Cardiovascular Disease and COVID-19 Vaccines
Author(s): Abdulrhman Khaity , Ala’ Abdala Mohamad Rababah , Omar A Abdelwahab , et al Added: 1 year ago

COVID-19

CV Disease in Special Populations